Our latest publication, Considerations and interactions with GLP-1 receptor agonists, summarises common issues highlighted to SPS by healthcare professionals with GLP-1 receptor agonists
Improved Insulin Sensitivity By supporting healthy NAD+ levels and improving mitochondrial efficiency, 5-Amino-1MQ enhances glucose uptake into cells, reducing blood sugar and improving fasting insulin
The metabolomics profiles of severe COVID-19 patients and patients with advanced cancer are similar, and in high-risk patients, SARS-CoV-2 infection leads to aberrant STAT3 activation, which promotes a cancer-like metabolism
Since GLP-1 receptor agonists are effective in addressing both weight management and insulin resistance - two significant factors in PCOS - they have become a valuable option for symptom management, even without FDA approval for this specific condition
International markets show mixed pricing pressure
It is a good illustration of what peptides do best: deliver a focused instruction to a chosen target rather than a systemwide boost